Targeted Therapies in Oncology. Second Edition

Targeted Therapies in Oncology. Second Edition. Edited by G. Giaccone, J.-C. Soria. 2014, pp. 480, £ 107.00, ISBN: 978-1-84214-545-6. CRC Press - Taylor & Francis Group, Boca Raton, FL, USA.

Since the last edition of this book, major advances have been made in our understanding of key pathways that control tumor progression. This has led to the development of new anticancer agents that have the ability to block the activity of proteins involved in neoplastic cell development and proliferation. Targeted Therapies in Oncology, Second Edition provides a concise timely panorama of existing targeted therapies and progress into future anticancer treatments.

These therapies notably include: Targeted agents of immune checkpoints; Signal-transduction inhibitors; Antiangiogenic agents; Vascular-disrupting agents; Apoptosis modulators; Stem cell inhibitors; Tumor profiling for drug development.

This book emphasizes the biology behind this new class of drugs as well as the clinical achievements obtained.